Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET Company Participants Bennett Watson - Investor Relations, ICR Westwicke Dan Barber - Chief Executive Officer Ernie Toth - Senior Vice President, Chief Financial Officer Steve Wargacki - Senior Vice President, Research and Development Ken Marshall - Senior Vice President, Chief Commercial Officer Conference Call Participants Jason Butler - JMP Securities Francois Brisebois - Oppenheimer Thomas Flaten - Lake Str ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share AQST NASDAQ Global Market FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commiss ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share AQST NASDAQ Global Market FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ C ...

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2022 Results Conference Call March 8, 2023 8:00 AM ET Company Participants Bennett Watson - Westwicke, Investor Relations Dan Barber - Chief Executive Officer Ernie Toth - Senior Vice President, Chief Financial Officer Steve Wargacki - Head of R&D Ken Truitt - Chief Medical Officer Ken Marshall - Chief Commercial Officer Conference Call Participants Francois Brisebois - Oppenheimer Thomas Flaten - Lake Street Capital Markets Ram Selvaraju - HC Wainwright James M ...

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2022 Earnings Conference Call August 3, 2022 8:00 AM ET Company Participants Bennett Watson - ICR Westwicke, Investor Relations Dan Barber - Chief Executive Officer Ernie Toth - Chief Financial Officer Dr. Steve Wargacki - VP of R&D Ken Marshall - Chief Commercial Officer. Conference Call Participants Evan Hua - BMO Securities Jason Butler - JMP Securities Thomas Flaten - Lake Street Capital Andreas Argyrides - Wedbush Ram Selvaraju - H.C. Wainwright James Mollo ...

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2022 Results Conference Call May 4, 2022 8:00 AM ET Company Participants Bennett Watson - Investor Relations Keith Kendall - Chief Executive Officer Ernie Toth - Chief Financial Officer Daniel Barber - Chief Operating Officer Conference Call Participants Jason Butler - JMP Securities Thomas Flaten - Lake Street Andreas Argyrides - Wedbush Securities Raghuram Selvaraju - HC Wainwright Operator Good day and thank you for standing by. I would now like to introduce ...